Recent Quotes (30 days)

You have no recent quotes
chg | %

The Biotech Growth Trust Plc  

(Public, LON:BIOG)   Watch this stock  
799.50
-5.50 (-0.68%)
Jun 23 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 799.50 - 815.00
52 week 517.86 - 815.00
Open 812.00
Vol / Avg. 13,405.00/76,620.00
Mkt cap 446.44M*
P/E 4.71
Div/yield     -
EPS 1.70*
Shares 55.84M
Beta     -
Inst. own     -
*GBP

Key stats and ratios

Q1 (Mar '17) 2017
Net profit margin 90.18% 95.00%
Operating margin 90.62% 95.28%
EBITD margin - 95.28%
Return on average assets 10.40% 22.17%
Return on average equity 10.91% 23.81%
CDP Score - -

Address

25 Southampton Buildings
LONDON, WC2A 1AL
United Kingdom - Map
+44-20-74264000 (Phone)
+44-20-72474722 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

The Biotech Growth Trust PLC is an investment trust. The Company's investment objective is to seek capital appreciation through investment in the biotechnology industry across the world. It invests in a diversified portfolio of shares and related securities in biotechnology companies. The Company will not invest more than 15%, in aggregate, of the value of its gross assets in other closed ended investment companies (including investment trusts) listed on the London Stock Exchange. The Company will not invest more than 15% of the value of its gross assets in any one individual stock at the time of acquisition. The Company will not invest more than 10% of the value of its gross assets in direct unquoted investments at the time of acquisition. OrbiMed Capital LLC is its portfolio manager. Frostrow Capital LLP is its alternative investment fund manager.